Is your decision to treat with hypofractionated radiation impacted by histology, ie lobular vs ductal cancers?   

What about tumor subtype, ie luminal A/B, Her2 positive, triple negative?



Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Academic Institution